ResearcherChinese PLA General HospitalActive in the last 2 years

Kai Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5411-2724; OpenAlex author ID A5087333671. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui Liu · 1 shared paper, 2025 · strength 0.30
- Paper ZMYND8 promotes the Warburg effect and tumorigenesis through c-Myc activation in pancreatic cancer. DOI 10.1038/s41388-025-03483-0 ↗
Chengyi Sun · 1 shared paper, 2025 · strength 0.30
- Paper ZMYND8 promotes the Warburg effect and tumorigenesis through c-Myc activation in pancreatic cancer. DOI 10.1038/s41388-025-03483-0 ↗
Yifeng Lei · 1 shared paper, 2017 · strength 0.07
- Paper Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer. DOI 10.1038/ncomms15130 ↗
Xingyu Jiang · 1 shared paper, 2017 · strength 0.07
- Paper Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer. DOI 10.1038/ncomms15130 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.